Get Involved

Why is this study important?

Problems with walking have been associated with memory decline with older people. Individuals may slow down, take smaller steps or become more unsteady on their feet. We are particularly interested in walking patterns of people with memory problems, and how these patterns relate to symptoms affecting memory and thought processes.

What is the aim of this study?

We aim to assess the memory and walking of people involved in the study using memory tasks and walking patterns alongside a small monitor worn over seven days. This is to understand if there is a relationship between the way someone walks and their memory.

What do people in this study have to do?

Visit 1 – you will be invited to the Clinical Ageing Research Unit (CARU). You will be asked to complete a series of questions about your general health and mood, and have some memory tests lasting approximately 2 hours.

Visit 2 –will take approximately an hour and a half. This will involve a walking assessment under different conditions. You are then asked to wear a small monitor for seven days to monitor your walking while going about your usual routine.

Recruitment to this study is due to end on …

July 2018

A summary of the study findings should be available by …

November 2018

Clinical Trials in Dementias and Neurodegeneration (DeNDRoN)

Select a trial from the list below to find out more about what it’s all about and how you can get involved in helping others.

ACDC

People who have Lewy body dementia, either Parkinson’s disease dementia or dementia with Lewy bodies, can have hallucinations. These hallucinations are often visual and may be disturbing for patients. The AC-DC study is the first treatment study aimed at reducing hallucinations.

Brains for Dementia Research

Brains for Dementia Research makes it easy for people to help research by donating brain tissue after death. Research using brain tissue from people who did not have dementia is important too.

AD Genetics in Early Onset Alzheimer’s Disease

The AD Genetics – Early Onset Alzheimer’s Disease research study is for people with a diagnosis of Alzheimer’s disease before the age of 65. Participants will be visited at a time and place convenient for them, usually in their own homes. The blood samples, interviews and memory tests take less than 2 hours. The participant’s partner, carer or family member will be interviewed at the same time.

SHAPED

Study of HAllucinations in Parkinson’s disease, Eye disease and Dementia

SUPErB

123I-MIBG Scintigraphy Utility as a biomarker for Prodromal Dementia with Lewy Bodies (SUPErB)

GAITDEM 20642

A study to assess the memory and walking of people

Investigating skin metabolites as a new way to diagnose Parkinson’s disease

This is a research study to investigate the chemicals known as metabolites found on the skin of people with Parkinson’s disease (PD).

Parkinson’s pen project (PPP): Developing a novel non-invasive aid for early diagnosis of Parkinson’s disease

Researchers at a number of universities across Europe (including Newcastle University) have developed a pen system (the Manus platform), which may help doctors to decide whether someone has Parkinson’s disease. Find out more here.


Latest news from PPI

View all